International AIDS Society


Now 16337 members from 183 countries | 

The United States National Institutes of Health, the Centers for AIDS Research and the International AIDS Society announce a new round of innovative HIV research awards


10 June 2011 (Geneva, Switzerland) – The International AIDS Society (IAS), in partnership with the U.S. National Institutes of Health (NIH) and the NIH-supported Centers for AIDS Research (CFAR), today announced the launch of a new round of the joint research grant programme, Creative and Novel Ideas in HIV Research (CNIHR).

The CNIHR programme supports projects intended to advance the scientific understanding of HIV by exploring new approaches to pressing scientific questions on such issues as the long-term survival of individuals with HIV infection, strategies to control viral reservoirs and research leading toward a cure for HIV/AIDS, and new approaches for the prevention of HIV transmission including treatment as prevention. “The NIH is delighted to continue this important international partnership, which is designed to promote innovative research and new ideas from early-stage investigators whose primary focus has previously been in fields of scientific inquiry other than HIV/AIDS,” Dr Jack Whitescarver, NIH Associate Director for AIDS Research and Director of the Office of AIDS Research, said. “The science of AIDS is making important strides, and we need to continue to generate innovative ideas and build multi-disciplinary collaborations. We must recruit and train tomorrow’s leading HIV researchers from across many areas of science, whose work will benefit not only HIV, but other fields of research as well.”

Given the limited resources available to pursue the rollout of antiretroviral therapy (ART) to all who need it, as well as the fact that in resource-limited settings, new infections continue to outstrip numbers of people on treatment by two to one, there is a strong need for continued investments to find new strategies to tackle the HIV epidemic. “In the current economic climate of treatment funding shortages and with a scale of unmet need that can only increase, the IAS is highly concerned by the long-term sustainability of antiretroviral therapy rollout,” Elly Katabira, IAS President, said. “Along with our partners, the IAS is committed to investing in finding better and more cost-effective options to curb the epidemic. One of the ways we can pursue this is through the CNIHR research grant programme.”

The first round of grants was announced in 2010. The joint programme awarded a total of US$3.4 million to fund the research projects of outstanding early-stage researchers. Each awardee is funded for up to two years with up to $150,000 (direct costs) per year plus applicable indirect costs.

“The truly international nature of this programme – it is open to candidates globally – enables it to select the best research projects from all over the world,” Prof Michael Saag, Director of CFAR at the University of Alabama at Birmingham, commented. “The first 10 awardees come from a wide range of scientific disciplines and locations, including Australia, India, Mexico, South Africa, the United Kingdom and the United States.”

The first step of the competitive application process is now open on the CNIHR website (www.cnihr.org) and will close on 17 October 2011. Applicants will be asked to complete a two-step process to assess the quality of their research projects. Awardees will be selected by mid-April 2012 and will be able to start their research projects in June 2012. The research projects will be supported in collaboration with a CFAR institution with expertise in each candidate’s area of proposed research.

“Through this programme, promising young researchers have access to CFAR’s solid expertise and infrastructure, which is extremely important for the success of their projects,” Prof King Holmes, Director of the CFAR at the University of Washington, said. Awardees will also have the chance to take part in a networking and training programme at the XIX International AIDS Conference (AIDS 2012), which will be held in Washington D.C. on 22-27 July 2012, where the results of the selection process will be announced.

About the IAS

The International AIDS Society (IAS) is the world’s leading independent association of HIV professionals, with more than 16,000 members from almost 200 countries working at all levels of the global response to AIDS. Our members include researchers from all disciplines, clinicians, and public health and community practitioners on the frontlines of the epidemic, as well as policy and programme planners. The IAS is the custodian of the biennial International AIDS Conference and lead organizer of the IAS Conference on HIV Pathogenesis, Treatment and Prevention, the next one of which will be held in Rome, Italy, in July 2011.

About NIH

The U.S. National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, behavioral and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

About CFAR

The Centers for AIDS Research (CFAR) programme at the National Institutes of Health provides administrative and shared research support to synergistically enhance and coordinate high-quality AIDS research projects. CFAR accomplishes this through core facilities that provide expertise, resources and services not otherwise readily obtained through more traditional funding mechanisms. The CFAR programme emphasizes the importance of interdisciplinary collaboration, especially between basic and clinical investigators, and translational research in which findings from the laboratory are brought to the clinic and vice versa. It also places emphasis on inclusion of minorities and inclusion of prevention and behavioural change research. Both the University of Alabama at Birmingham CFAR and the University of Washington CFAR in Seattle participate in the CNIHR grant programme.

Visit www.niaid.nih.gov/labsandresources/resources/cfar/Pages/default.aspx

References

CNIHR grant website: www.cnihr.org

Information on 2010 awardees: www.iasociety.org/Default.aspx?pageId=381

For more information

Lindsey Rodger
Communications Officer
Email:
Tel: +41 22 710 0822  
Want to share your opinion on the subject? Post your comments below.

The comments on this page do not necessarily reflect the views of the International AIDS Society.

First Name(s): (Initial)
  
Last Name(s): (Initial)
 
Email: (Will not show)
Organisation: (Optional)
Country: (Optional)
Comment:

Comments
Posted: 21 July 2011
By:  K P  WongKenya
Comment:
I propose a research into creating a protein substance that mimics a CD4. We introduce this pseudo CD4 into the blood stream. HIVs will be tricked to latch onto them, binding themselves onto the pseudo CD4. This will naturally deprive the HIV's ability to reproduce since the pseudo CD4 is not real, or the HIV together with the pseudo CD4 will eventually be destroyed by the body's natural immune mechanism as a single pathogen. This is not a cure but would be far better than current treatment with drugs, as the pseudo CD4 does not interfere with the biological functions of the body and therefore unlikely to present adverse side effects.
Posted: 29 June 2011
By:  Gloria  Theophilus. KHIV/AIDS Education and Development Centre in Bori-Ogoni- Rivers StateNigeria
Comment:
This trend in research is encouraging as far as rural based research in developed country will be one of the target. I still believe that until donors follow their money, monitor and srtongly call for greater level of accountablity nothing will change especially in most developed country. Donors need to control where their money goes, rural based programming and research is still lacking. Our program provide services in rural villages in Ogoni with no funding, even though it is a known fact currently that the highest cases of HIV/AIDS is coming from this rural areas. Our programs need help in term of research and other structured funded program. We are looking for institutions and organizations to partner with us in Ogoni where little or no work has been done in terms of research. Please visit our website at boriaidsprogram.org to see all the work we have done sacrifically with proven result.
Posted: 23 June 2011
By:  Alemitu  GultieEthiopia
Comment:
I'm working on workplace HIV na dAIDS interventions.I'm happy to hear your effort for further research for the cure, the medicine with lower cost especially for for poor countries. What about researches for the prevention?
 
PDF version

Download this statement in PDF format


Post to:

Delicious Delicious  Digg   Facebook